Company intelligence / Profile preview

Guizhou Baite Pharmacy

Guiyang, Guizhou, China

Ownership: Private
Development stage: Other

Overview

Guizhou Baite Pharmaceutical is a specialized pharmaceutical manufacturer based in Guiyang, China, primarily focused on oncology therapeutics. Established in 1994, the company is a wholly-owned subsidiary of Jiangsu Hengrui Pharmaceuticals, one of China's largest drug manufacturers. Guizhou Baite is best known for its production of paclitaxel injections and other taxane-based chemotherapy agents. The company maintains high-standard GMP manufacturing facilities dedicated to the extraction and processing of anti-tumor compounds from natural sources. It serves as a critical production hub for Hengrui's oncology portfolio, supporting the domestic supply of essential cancer treatments.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Pharma

Beyond the preview

Go deeper on Guizhou Baite Pharmacy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guizhou Baite Pharmacy.

Explore the full profile